Faculty

Erin F. Barreto, Pharm.D., Ph.D., R.Ph., BCCCP

Clinical Studies

A Mixed Methods Study Of AKI Survivor Communication Guides Rochester, MN
The purpose of this study is to pilot test a newly developed communication tool designed to enhance information transfer between health care providers caring for survivors of acute kidney injury (AKI), evaluating its feasibility, acceptability, and preliminary impact on care coordination and clinical workflow efficiency. We hypothesize that the new communication tools will be feasible and acceptable to patients, caregivers, and clinicians alike.
Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial Rochester, MN
The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for AKI survivors on patient-centered outcomes, a randomized trial is needed.

Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial Eau Claire, WI La Crosse, WI Mankato, MN
The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for AKI survivors on patient-centered outcomes, a randomized trial is needed.

AKI in Care Transitions (ACT) Trial (AKI ACT) Rochester, MN
The purpose of this study is to evaluate the feasibility and acceptability of the AKI in Care Transitions pilot and iteratively refine the intervention. Generate preliminary estimates of the ACT intervention on clinical and patient-reported outcomes.
Enhanced Kidney Follow-up for AKI Survivors in Care Transitions (The ACT Study): Impact on Patient Reported Outcomes (ACT Study) Rochester, MN
The purpose of this study is to assess the ability of education and outpatient kidney care follow-up to improve patient knowledge about acute kidney injury (AKI).
Pharmacokinetic Evaluation of Antipseudomonal Beta-lactams in Critically Ill Patients (Prospective BLOOM) Rochester, MN
The purpose of this study is to observe and characterize the pharmacokinetics of anti-pseudomonal beta-lactam antibiotics (cefepime, piperacillin/tazobactam, meropenem) in critically ill adults..